Bayer CropScience Ltd

Bayer CropScience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 21 June 2026, providing investors with an up-to-date perspective on the company’s standing.

For the second consecutive session, Bayer CropScience Ltd has declined, hitting a fresh 52-week low of Rs 4,192.7 on 17 Jun 2026, marking a 2.01% drop over the last two days amid broader sector weakness.

A sharp decline has pushed Bayer CropScience Ltd to a fresh 52-week low of Rs 4,230.9 on 11 Jun 2026, marking a significant 35.3% drop from its peak of Rs 6,539.95 within the last year. This downturn comes despite some encouraging financial metrics, highlighting a complex interplay of valuation concerns and market sentiment.

Bayer CropScience Ltd is rated Sell by MarketsMOJO, with this rating last updated on 18 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 10 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Bayer CropScience Ltd’s share price declined to a fresh 52-week low of Rs.4248 on 09 Jun 2026, marking a continuation of recent downward momentum amid broader market pressures and company-specific valuation concerns.

A sharp decline over the past two sessions has dragged Bayer CropScience Ltd to a fresh 52-week low of Rs 4265.4 on 8 Jun 2026, marking a 3.25% drop in just 48 hours amid broader sector weakness and persistent selling pressure.

Bayer CropScience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 30 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Bayer CropScience Ltd., a leading player in India's agrochemicals sector with a market capitalisation of ₹20,927 crores, reported net profit of ₹162.10 crores for Q4 FY26, marking a 13.12% year-on-year increase but a significant 69.38% sequential improvement from the previous quarter. Despite the profitability recovery, the company's shares have struggled, declining 17.98% over the past year and currently trading at ₹4,656.45, down 28.80% from their 52-week high of ₹6,539.95.

Bayer CropScience Ltd has seen its investment rating downgraded from Hold to Sell as of 18 May 2026, reflecting a combination of deteriorating technical indicators, expensive valuation metrics, subdued financial growth trends, and weakening market momentum. Despite some positive quarterly financial results, the stock’s overall outlook has turned cautious amid persistent underperformance against benchmarks and bearish technical signals.

Bayer CropScience Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to a more pronounced bearish trend. The stock’s recent price action, combined with deteriorating moving averages and bearish MACD and Bollinger Bands readings, suggests increasing downside pressure amid a challenging market environment for the pesticides and agrochemicals sector.

Bayer CropScience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 Apr 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 13 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Bayer CropScience Ltd is currently rated 'Hold' by MarketsMOJO, with this rating last updated on 20 Apr 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 02 May 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook.

Bayer CropScience Ltd has seen its investment rating upgraded from Sell to Hold as of 20 April 2026, reflecting a nuanced improvement across valuation, financial trends, quality metrics, and technical indicators. The company’s valuation grade has shifted from very expensive to expensive, supported by robust quarterly financial results and a strong return on equity, despite some challenges in long-term growth and recent price volatility.

Bayer CropScience Ltd, a key player in the Pesticides & Agrochemicals sector, has seen its investment rating downgraded from Hold to Sell as of 15 Apr 2026. This shift is primarily driven by a reassessment of its valuation metrics, despite the company’s robust financial performance and operational efficiency. The downgrade reflects a nuanced view of the stock’s quality, valuation, financial trends, and technical indicators, signalling caution for investors amid an increasingly expensive market positioning.

Bayer CropScience Ltd, a key player in the Pesticides & Agrochemicals sector, has seen its valuation parameters shift markedly, with price-to-earnings (P/E) and price-to-book value (P/BV) ratios moving into the 'very expensive' territory. This change has prompted a downgrade in its MarketsMOJO Mojo Grade from Hold to Sell, reflecting concerns over stretched valuations despite solid operational returns and recent price gains.

Bayer CropScience Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 30 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.